Oddo BHF - NOVO NORDISK A/S (NOVO B) Novo Nordisk : Steps have been taken to accelerate the penetration of Wegovy

Report

Oddo BHF

Damien Choplain ...

Martial Descoutures

Novo Nordisk : Steps have been taken to accelerate the penetration of Wegovy

16/05/2025 1 EN

Underlying

NOVO NORDISK A/S

See profile

DK0062498333 Nasdaq Nordic Copenhagen Denmark

Provider

Oddo BHF

Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

See profile

Analysts

Damien Choplain

Martial Descoutures

Other Reports on these Companies

GlobeNewsWire

Novo Nordisk A/S - share repurchase programme

Novo Nordisk A/S - share repurchase programme Bagsværd, Denmark, 9 March 2026 – On 4 February 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 15 billion to be executed during a 12-month period beginning 4 February 2026. Under the programme initiated 4 February 2026, Novo Nordisk will repurch...

March 9, 2026 March 9, 2026 1 EN

GlobeNewsWire

Election of employee representatives to the Board of Directors of Novo Nordisk A/S

Election of employee representatives to the Board of Directors of Novo Nordisk A/S Bagsværd, Denmark, 2 March 2026 – The employees in Novo Nordisk A/S have completed the election of employee representatives to the Board of Directors of Novo Nordisk A/S. The following employee representatives were elected for the next four years: Semsi Kilic Madsen (new)Mette Bøjer Jensen (re-elected)Elisabeth Dahl Christensen (re-elected)Désirée Jantzen Asgreen (new) The following were elected as substitutes for the employee-elected board members: Trine Hartvig KristiansenTamara SchmidtTanja VillumsenHa...

March 2, 2026 March 2, 2026 1 EN

GlobeNewsWire

Novo Nordisk A/S - share repurchase programme

Novo Nordisk A/S - share repurchase programme Bagsværd, Denmark, 2 March 2026 – On 4 February 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 15 billion to be executed during a 12-month period beginning 4 February 2026. Under the programme initiated 4 February 2026, Novo Nordisk will repurch...

March 2, 2026 March 2, 2026 1 EN

Cosmo Pharmaceuticals : Révision CT, maintien des objectifs MT

3h / 6m 3h / 6m 1 FR

Martial Descoutures ... (+2)

Martial Descoutures
Oussema Denguir

Cosmo Pharmaceuticals : Short-term revision, medium-term targets maintained

3h / 6m 3h / 6m 1 EN

Baptiste Salaville ... (+2)

Baptiste Salaville
Julian Dobrovolschi

ODDO BHF SECURITIES LARGE CAPS MORNING NEWS 03/10/2026

3h / 12m 3h / 12m 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Novo Nordisk : Steps have been taken to accelerate the penetration of Wegovy

Novo Nordisk A/S - share repurchase programme

Election of employee representatives to the Board of Directors of Novo Nordisk A/S

Novo Nordisk A/S - share repurchase programme

Cosmo Pharmaceuticals : Révision CT, maintien des objectifs MT

Cosmo Pharmaceuticals : Short-term revision, medium-term targets maintained

ODDO BHF SECURITIES LARGE CAPS MORNING NEWS 03/10/2026

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe